Together we will beat cancer

Donate

‘Cutting edge’ CAR T cell immunotherapy approved in England. But is the NHS ready?

With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.

Read More

Nobel Prize 2018: How Allison and Honjo turned immune cells against cancer

Dr James Allison and Professor Tasuku Honjo have been given a Nobel Prize for revolutionising our understanding of how the immune system sees cancer.

Read More

Urine liquid biopsies could help monitor bladder cancer treatment

Scientists have shown for the first time that immune cells in the urine of bladder cancer patients accurately reflect those in the tumour environment.

Read More

Exploiting the brain tumour environment to make better treatments

Brain tumours are heavily influenced by their surroundings so understanding the environment they’re in could reveal ways to destroy them.

Read More

Finding common ground with arthritis could help cancer patients

Our new research partnership is exploring common ground between arthritis and cancer, which could bring benefits to patients on both sides.

Read More

From cancer evolution to targeting faulty genetics – our new fellows

Find out the burning questions some of our researchers want to answer as they set up their own research teams for the first time.

Read More

Cancer blood tests and learning from HIV – our latest Pioneer Awards

Drawing similarities between how the immune system reacts to lung cancer and HIV could uncover potential new drug targets.

Read More

Lung cancer discovery points to a better way to personalise immunotherapy

New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.

Read More

8 new challenges between us and beating cancer

We launch phase 2 of our Grand Challenge with 8 of the biggest questions in cancer research.

Read More

ASCO 2017: 4 ways treatment could change following world’s largest cancer conference

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.

Read More